# Phase 3 Independent Internal Audit

## Scope and methodology

This audit was performed against the current implementation and tests without relying on prior Phase 3 reports. It traced the connected lifecycle from Phase 2 authentication through panel construction, estimation, diagnostics, staging, activation, manifest binding, listing, and read-time authentication. It separately reviewed model equations, return units, risk-free/date alignment, future information, covariance/rank checks, model ordering, failure modes, schemas, restart behavior, CLI exposure, configuration identity, Git diff, dependencies, secrets, generated artifacts, and documentation.

Adversarial probes mutated future availability, common-factor values, factor availability, model names, design rank, weights, lags, dates, cross-sectional counts, and persisted artifact bytes. Known-coefficient and future-mutation probes challenged numerical correctness and rolling isolation. An identical restart challenged deterministic reuse. Output inspection challenged exact artifact inventory and schemas.

## Findings discovered and remediated

| ID | Severity | Finding | Remediation and evidence | Status |
|---|---|---|---|---|
| P3-AUD-H01 | High | The initial Phase 3 panel rejected factor evidence available after its date but allowed a realized portfolio row whose availability date was later than its return date. A rolling estimate indexed only by return date could therefore include evidence not yet available at that window end. | Phase 3 now requires realized portfolio availability on its observation date. A delayed-evidence adversarial regression test must raise `TemporalIntegrityError`. | CLOSED |
| P3-AUD-M01 | Medium | Model dictionary/request order could create distinct semantically equivalent publication ordering. | Model selections are canonicalized by sorting before estimation and publication identity construction. | CLOSED |
| P3-AUD-M02 | Medium | Parquet artifacts were checksum/size bound and parse-checked but the authenticator did not initially require the exact output column set. | Exact required columns are now enforced for all five Parquet artifact types during complete-bundle authentication. | CLOSED |

## Audit conclusions

| Area | Result | Basis |
|---|---|---|
| Regression engine | PASS | Analytical recovery; estimator/covariance variants; explicit errors |
| Statistical assumptions | PASS | Named residual, heteroskedasticity, autocorrelation, stationarity, VIF, influence tests |
| Model reproducibility | PASS | Canonical config/model identity and identical-run reuse |
| Artifact authentication | PASS | Full inventory, manifest/pointer, checksum, size, schema, JSON identity |
| Lineage | PASS | Parent manifest hash, Phase 2 ID, config hash, Git commit, transformation |
| Calendar and risk-free alignment | PASS | Exact dates, decimal-return subtraction, no fill/substitution |
| Rolling temporal isolation | PASS | Unique ordered dates, explicit bounds, future-mutation and delayed-evidence rejection |
| Restart/crash behavior | PASS | Pre-activation evidence invisible; deterministic retry; conflicting bytes refused |
| CLI and configuration | PASS | Strict config hash; explicit compute/list/verify commands; nonzero platform error boundary |
| Documentation | PASS | Current status, methods, contracts, limitations, and phase boundary aligned |

## Remaining limitations and defect register

No Critical, High, Medium, or merge-blocking defect remains open. The following Low limitations are disclosed and are not software bypasses:

| ID | Severity | Limitation | Merge blocking |
|---|---|---|---|
| P3-L01 | Low | Phase 3 uses project-specific characteristic spreads, not official provider replicas; empirical equivalence is not claimed. | No |
| P3-L02 | Low | Validation uses deterministic synthetic fixtures and does not establish live-data coverage, model fitness, causality, or investability. | No |
| P3-L03 | Low | Prediction-interval support is available for forecast contexts, but retrospective fitted-value publications do not mislabel in-sample uncertainty as a forecast interval. | No |

## Verdict

Zero Critical findings, zero High findings, and zero merge blockers remain. Phase 3 acceptance criteria pass. Phase 4 is authorized as the next phase but remains unimplemented.

**PHASE 3 COMPLETE — READY FOR INDEPENDENT ASSURANCE**
